NCT03082092View on ClinicalTrials.gov

Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

June 1, 2019

Study Completion Date

June 1, 2019

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Methylprednisolone Sodium Succinate

single intravenous dose of 125mg methylprednisolone diluted in 2.1ml of diluent given on induction of total knee replacement

DRUG

Placebos

0.9% intravenous saline (2.1ml) intravenously on induction of total knee replacement

Trial Locations (1)

Unknown

Queen Elizabeth Hospital, Hong Kong

All Listed Sponsors
lead

Queen Elizabeth Hospital, Hong Kong

OTHER

NCT03082092 - Pre-operative Intravenous Steroid in Total Knee Replacement for Pain Relief and Recovery | Biotech Hunter | Biotech Hunter